JMI Hospital Requisite Manufacturing Limited announcements
103 Dhaka Stock Exchange announcements for JMI Hospital Requisite Manufacturing Limited (JHRML) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (24).
- Alpha Credit Rating Limited (Alpha Rating) has assigned the surveillance rating of the Company as \"A+\" in the long ter
Alpha Credit Rating Limited (Alpha Rating) has assigned the surveillance rating of the Company as \"A+\" in the long term and \"ST-2\" in the short term along with a stable outlook based on audited financial statement of the company for the year ended June 30, 2022 and relevant qualitative information till December 26, 2022.
- Special resolution regarding related party transaction
The company has informed that they have decided to place an agenda to approve related party transaction for the year ended June 30, 2022, among others, as special business for approval of shareholders in 14th AGM scheduled to be held on January 12, 2023 at 11:00 AM. Special resolution: Resolved that the related party transactions of the sister concern of the Company are hereby approved by the board of directors, that the matter be placed before the upcoming 14th AGM for approval by the shareholders.
- Regarding Office Address
The Company has informed that the construction works are ongoing in their Registered office address at Holdings # 72/C, Progoti Shoroni, Middle Badda, Dhaka-1212 and they mentioned Corporate office and mailing address at Unique Heights (Level -11), 117 Kazi Nazrul Islam Avenue, Ramna, Dhaka- 1217 for easy communication.
- Resumption after record date
Trading of the shares of the Company will resume on 01.12.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 28.11.2022 to 29.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2022.
- Dhaka Stock Exchange Limited (DSE) has approved the proposed sector change of the Company. Accordingly, the business sec
Dhaka Stock Exchange Limited (DSE) has approved the proposed sector change of the Company. Accordingly, the business sector of JMI Hospital Requisite Manufacturing Limited will be changed to \"Pharmaceuticals & Chemicals \" instead of \"Miscellaneous\" sector with effect from November 23, 2022. Other things (except sector) will remain unchanged.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.53 for July-September 2022 as against Tk. 0.64 for July-September 2021; NOCFPS was Tk. 0.91 for July-September 2022 as against Tk. 1.46 for July-September 2021. NAV per share was Tk. 31.49 as on September 30, 2022 and Tk. 32.13 as on September 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- The Board of Directors has recommended 12.50\% cash dividend for the year ended June 30, 2022. Date of AGM: 12.01.2023,
The Board of Directors has recommended 12.50\% cash dividend for the year ended June 30, 2022. Date of AGM: 12.01.2023, Time: 11:00 AM, Venue: Digital Platform. Record Date: 30.11.2022. The Company has also reported EPS of Tk. 3.25, NAV per share of Tk. 38.84 and NOCFPS of Tk. 4.26 for the year ended June 30, 2022 as against Tk. 2.50, Tk. 31.49 and Tk. 3.04 respectively for the same period of the previous year. (cont.)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (26.10.2022) following its corporate declaration.
- Dividend Declaration and Revision of the use of IPO Proceeds
(Continuation news of JHRML): The Board of Directors of the company has also approved and recommended to revise the use of IPO proceeds, due to Covid-19, Changes of exchange rate, Russia-Ukraine war and adding new component of machinery as well as new machinery line subject to the approval of shareholders in the upcoming 14th AGM and Bangladesh Securities & Exchange Commission. (end)
The first part of this announcement is missing from the archive. - Update of Information
The Company has requested the Shareholders to check and update their BO IDs, Bank accounts, e-mail IDs, 12 digit E-TIN and other necessary information before Record Date i.e. November 30, 2022.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 25, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Query Response
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.60 for January-March 2022 as against Tk. 0.49 for January-March 2021; EPS was Tk. 2.89 for July 2021-March 2022 as against Tk. 1.70 for July 2020-March 2021. NOCFPS was Tk. 2.38 for July 2021-March 2022 as against Tk. 2.61 for July 2020-March 2021. NAV per share was Tk. 30.69 as on March 31, 2022 and Tk. 31.49 as on June 30, 2021.
- Decision to purchase land
The Company has informed that the Board of Directors has approved a cost of BDT. 4,25,00,000 in connection to acquire of 34 decimal land including its registration cost and development of the same at adjacent to the existing project site, Vitikandi, Gazaria, Munshigonj, in the name of JMI Hospital Requisite Manufacturing Limited for its expansion and payment for the same will be made from IPO proceeds.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2022 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Trading of the shares of JMI Hospital Requisite Manufacturing Limited will commence at DSE from today i.e. March 31, 202
Trading of the shares of JMI Hospital Requisite Manufacturing Limited will commence at DSE from today i.e. March 31, 2022 under \'N\' category. DSE Trading Code for JMI Hospital Requisite Manufacturing Limited is \"JHRML\" and DSE Company Code is 99644.
- (Q2 Un-audited): As per un-audited Q2 financial statements, profit after tax is BDT 59.77 million and basic EPS of BDT 0
(Q2 Un-audited): As per un-audited Q2 financial statements, profit after tax is BDT 59.77 million and basic EPS of BDT 0.66 for the 3 (three) months (October-December 2021) period ended 31 December 2021 against profit after tax of BDT 54.60 million and basic EPS of BDT 0.61 for the same period of the previous year. (cont. 1)
- (Continuation news of JHRML): However, Post-IPO basic EPS for the 3 (three) months (October-December 2021) period ended
(Continuation news of JHRML): However, Post-IPO basic EPS for the 3 (three) months (October-December 2021) period ended 31 December 2021 would be BDT 0.48. Moreover, profit after tax is BDT 116.21 million and basic EPS of BDT 1.29 for the 6 (six) months (July-December 2021) period ended 31 December 2021 against profit after tax of BDT 109.21 million and basic EPS of BDT 1.21 for the same period of the previous year. (cont. 2)
The first part of this announcement is missing from the archive. - (Continuation news of JHRML): However, Post-IPO EPS would be BDT 0.93 for 6 (six) months (July-December 2021) period end
(Continuation news of JHRML): However, Post-IPO EPS would be BDT 0.93 for 6 (six) months (July-December 2021) period ended 31 December 2021. Pre-IPO Net Asset Value (NAV) per share (considering Pre-IPO paid up shares) would be BDT 32.78 as on 31 December 2021 and the same would be BDT 29.54 (considering Post-IPO paid up shares). (cont. 3)
The first part of this announcement is missing from the archive. - Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of JMI Hospital Requisite Manufacturing Limited in between 1st to 30th trading days starting from today i.e. March 31, 2022 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
- Q2 Financials
(Continuation news of JHRML): Pre-IPO weighted average paid-up number of shares for 3 (three) months (October-December 2021) and 6 (six) months (July-December 2021) period ended 31 December 2021 was 90,000,000 which was same for the same period of the previous year and Post-IPO paid-up number of shares would be 125,294,120. (end)
The first part of this announcement is missing from the archive.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.